FLORIDA: President-elect Donald Trump said on Thursday he has selected Robert F. Kennedy Jr, an environmental activist who has spread misinformation on vaccines, to lead the Department of Health and Human Services, the United States’ top health agency.
In a post on X, Kennedy vowed to work to end chronic disease, clean up corruption and provide Americans with the data they need to make informed decisions, vowing to Trump he would work to “Make America Healthy Again”.
Kennedy ran for president in this year’s election as an independent before dropping out in August and endorsing Trump in exchange for a role in the Republican administration.
Kennedy, the son and nephew of two titans of Democratic politics, has frequently talked about tackling what he calls the “chronic disease epidemic” of conditions including obesity, diabetes and autism, and reducing chemicals in food.
“The safety and health of all Americans is the most important role of any administration, and HHS will play a big role in helping ensure that everybody will be protected from harmful chemicals, pollutants, pesticides, pharmaceutical products, and food additives that have contributed to the overwhelming health crisis in this country,” Trump said in a post on social media.
Later on Thursday during a speech at his Mar-a-Lago home in Florida, Trump praised Kennedy, saying he would do “unbelievable” things in his new position. “We want you to come up with things and ideas and what you’ve been talking about for a long time,” Trump said, without elaborating.
The Department of Health and Human Services oversees drug regulation, public health agencies including the Centres for Disease Control and Prevention and health insurance for more than 140 million people including the poor, those aged 65 and older, and the disabled through Medicare and Medicaid.
HHS had a $3.09 trillion budget for fiscal year 2024, representing 22.8 per cent of the US federal budget.
Drew Altman, president of health research firm KFF, described the move as historic and said what Kennedy, if confirmed, would ultimately do in the role remains to be seen, given he has not often discussed programs like Medicaid and Medicare, which account for much of the US health budget.
“Historically, secretaries have been people with real experience and standing in national healthcare and he certainly is not that, and has views from outside the mainstream, and is a renegade appointment,” Altman said.
The appointment, which had been seen as a possibility for weeks, raised concern among some public health advocates who said Kennedy could have a negative role in Americans’ health given his power over these agencies. The Democratic Party decried the decision.
Some politicians and business groups supported the nomination, such as the National Community Pharmacists Association, which said it was encouraged by his willingness to take on corporations.
Health Priorities
Kennedy has been a part of Trump’s transition team and has been reviewing candidate resumes for the top jobs at US health agencies.
Kennedy has suggested he would gut the 18,000-employee Food and Drug Administration — which ensures the safety of food, drugs and medical devices — and replace hundreds of employees at the National Institutes of Health.
“FDA’s war on public health is about to end,” he wrote on X in late October, adding that includes its “aggressive suppression” of psychedelics, peptides, stem cells, raw milk, sunshine, and other items.
“If you work for the FDA and are part of this corrupt system, I have two messages for you: 1. Preserve your records, and 2. Pack your bags,” he wrote.
In early November, he said he would recommend fluoride be removed from public water supplies, falsely claiming on X that the chemical is associated with bone fractures and cancer.
In a New York Times opinion article published in September, Kennedy criticised the popular Novo Nordisk weight loss drug Ozempic, saying, “Instead of fixing our food system and addressing the obesity crisis at its root, the author focuses on a drug that may palliate the symptom and gladden the wallets of distant Big Pharma execs.”
Dr Ashish Jha, former White House Covid-19 Response Coordinator and dean of the Brown University School of Public Health, said: “Most people don’t realise this is not about fluoride in water, or even vaccines, as important as they are. The HHS Secretary oversees Medicare. He and his appointees will decide what medicines are available to the American people.”
James Capretta, senior fellow at the American Enterprise Institute and a former White House staffer under George W. Bush, said it is not clear what impact Kennedy will have but that it will not be immediate.
“There’s lots of constraints on policy-making on the agency level, even at the secretarial level,” he said.
